A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
2026-09-10
عنوان الدراسة
A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
داعم الدراسة
ModernaTX, Inc./ Balsam CR
دواء الدراسة
mRNA-3927
رقم بروتوكول الدراسة
mRNA-3927-P101-EXT
حالة الدراسة
Ongoing
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
1/2
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.